摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-Fluorophenyl)piperazin-2-one | 907972-55-8

中文名称
——
中文别名
——
英文名称
1-(2-Fluorophenyl)piperazin-2-one
英文别名
——
1-(2-Fluorophenyl)piperazin-2-one化学式
CAS
907972-55-8
化学式
C10H11FN2O
mdl
——
分子量
194.21
InChiKey
XADOLDIXWGJVRV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    389.0±37.0 °C(Predicted)
  • 密度:
    1.225

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Ligands of melanocortin receptors and compositions and methods related thereto
    申请人:Tucci C. Fabio
    公开号:US20050119252A1
    公开(公告)日:2005-06-02
    Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders. The compounds have the following structure (I): including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein m, n, q, s, R 1 , R 1a , R 1b , R 2 , R 3 , R 4a , R 4b , R 5a , R 5b , X 1 , X 2 , X 3 , X 4 and Ar are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed.
    这是一种功能为黑素皮质素受体配体的化合物,可用于治疗基于黑素皮质素受体的疾病。该化合物具有以下结构(I):包括立体异构体,前药和其药学上可接受的盐,其中m,n,q,s,R1,R1a,R1b,R2,R3,R4a,R4b,R5a,R5b,X1,X2,X3,X4和Ar的定义如本文所述。还公开了含有结构(I)化合物的药物组成物,以及与其使用相关的方法。
  • [EN] LIGANDS OF MELANOCORTIN RECEPTORS AND COMPOSITIONS AND METHODS RELATED THERETO<br/>[FR] LIGANDS DE RECEPTEURS DE LA MELANOCORTINE, COMPOSITIONS ET PROCEDES ASSOCIES
    申请人:NEUROCRINE BIOSCIENCES INC
    公开号:WO2005042516A2
    公开(公告)日:2005-05-12
    Compounds which function as melanocortin receptor ligands and having utility in the treatment of melanocortin receptor-based disorders. The compounds have the following structure (I): (I) including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein m, n, q, s, R1, R1a, R1b, R2, R3, R4a, R4b, R5a, R5b, X1, X2, X3, X4 and Ar are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed.
  • [EN] PIPERAZINYL ANTIVIRAL AGENTS<br/>[FR] AGENTS ANTI-VIRAUX À BASE DE PIPÉRAZINYLE
    申请人:GLAXOSMITHKLINE LLC
    公开号:WO2011041713A2
    公开(公告)日:2011-04-07
    Provided are compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).
查看更多